<DOC>
	<DOCNO>NCT00691431</DOCNO>
	<brief_summary>This study compare clinical outcome fellow eye randomize either IntraLase femtosecond laser-created flap Hansatome mechanical keratome-created flap wavefront-guided laser situ keratomileusis .</brief_summary>
	<brief_title>IntraLase vs Hansatome Flaps LASIK</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion `` T 6.00 D spherical myopia , `` T 3.00 D refractive astigmatism , stable refraction ( less 0.50D per year sphere cylinder ) , corneal diameter le 11.0 mm allow suction fixation ring , soft contact wearer discontinuation wear least 7 day prior preoperative evaluation , visual acuity correctable least 20/20 eye , 21 year age , ability participate followup examination 12 month LASIK surgery . In order fairly compare visual outcome two keratomes , patient require closely matched eye , term refractive error . Exclusion criterion include rigid gas permeable contact lens wearer , severe dry eye , severe blepharitis , anterior segment pathology ( cataract corneal scar neovascularization within 1 mm intend ablation zone ) , recurrent corneal erosion , severe basement membrane disease , progressive unstable myopia keratoconus , unstable corneal mire central keratometry , corneal thickness LASIK procedure would result less 250 micros remain posterior corneal thickness flap postoperatively , baseline standard manifest refraction &gt; 0.75 D minus sphere power , difference great 0.50D cylinder power compare baseline standard cycloplegic refraction , two eye baseline standard cycloplegic refraction differ 0.75 sphere , 0.50 D cylinder , different type astigmatism ( i.e . withtherule ) cylinder &gt; 0.50D , preoperative assessment ocular topography and/or aberration indicate either eye suitable candidate LASIK vision correction procedure ( ie forme fruste keratoconus , corneal warpage , pellucid marginal degeneration ) , previous intraocular corneal surgery , history herpes zoster simplex keratitis , patient systemic corticosteroid immunosuppressive therapy , immunocompromised subject clinically significant atopic disease , connective tissue disease , diabetes , steroid responder , macular pathology , pregnant lactating patient , patient sensitivity plan study concomitant medication patient participate another ophthalmic drug device clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>